Estland - estisk - Ravimiamet

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 50tk

Estland - estisk - Ravimiamet

hospira uk limited - tseftriaksoon - süstelahuse pulber - 1g 1tk; 1g 25tk; 1g 10tk; 1g 5tk

Estland - estisk - Ravimiamet

hospira uk limited - tseftriaksoon - süstelahuse pulber - 500mg 10tk; 500mg 25tk

Estland - estisk - Ravimiamet

venus pharma gmbh - tseftriaksoon - süste-/infusioonilahuse pulber - 2g 10tk; 2g 1tk; 2g 5tk

Estland - estisk - Ravimiamet

venus pharma gmbh - tseftriaksoon - süste-/infusioonilahuse pulber - 1g 1tk; 1g 10tk

Den europeiske union - estisk - EMA (European Medicines Agency)

astrazeneca ab - olaparib - munasarjade kasvajad - antineoplastilised ained - munasarja cancerlynparza on näidustatud monotherapy eest:hooldus ravi täiskasvanud patsientidel, kellel on arenenud (figo etapid iii ja iv) brca1/2-muteerunud (germline ja/või somaatilise) kõrge-klassi epiteeli munasarja -, munajuha-või esmase peritoneaaldialüüsi vähi, kes on vastuseks (täielik või osaline) pärast lõpetamist esimese-line platinum põhineva keemiaravi. maintenance treatment of adult patients with platinum sensitive relapsed high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy. lynparza in combination with bevacizumab is indicated for the:maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy in combination with bevacizumab and whose cancer is associated with homologous recombination deficiency (hrd) positive status defined by either a brca1/2 mutation and/or genomic instability (see section 5. breast cancerlynparza is indicated as:monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline brca1/2-mutations who have her2-negative, high risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy (see sections 4. 2 ja 5. monotherapy for the treatment of adult patients with germline brca1/2-mutations, who have her2 negative locally advanced or metastatic breast cancer. patsientidel peaks olema varem ravitud mõne anthracycline ja taxane aastal (neo)abiaine või metastaatilise seade välja arvatud juhul, kui patsientidele ei sobi nende ravi (vt lõik 5. patsiendid, kellel on hormooni retseptori (hr)-positiivse rinnavähi peaks ka jõudnud või pärast eelneva endokriinse ravi, või pidada sobi endokriinse ravi. adenocarcinoma of the pancreaslynparza is indicated as:monotherapy for the maintenance treatment of adult patients with germline brca1/2-mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a minimum of 16 weeks of platinum treatment within a first-line chemotherapy regimen. prostate cancerlynparza is indicated as:monotherapy for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc) and brca1/2-mutations (germline and/or somatic) who have progressed following prior therapy that included a new hormonal agent. in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with mcrpc in whom chemotherapy is not clinically indicated (see section 5.

Estland - estisk - Ravimiamet

sandoz gmbh - amoksitsilliin - õhukese polümeerikattega tablett - 1000mg 10tk; 1000mg 100tk; 1000mg 12tk

Estland - estisk - Ravimiamet

sandoz pharmaceuticals d.d. - amoksitsilliin - õhukese polümeerikattega tablett - 1000mg 1000tk; 1000mg 28tk; 1000mg 20tk; 1000mg 14tk; 1000mg 7tk; 1000mg 10tk; 1000mg 16tk; 1000mg 100tk

Estland - estisk - Ravimiamet

medochemie limited - tseftriaksoon - süstelahuse pulber - 1000mg 100tk; 1000mg 50tk; 1000mg 1tk

Estland - estisk - Ravimiamet

sandoz pharmaceuticals d.d. - amoksitsilliin - õhukese polümeerikattega tablett - 500mg 30tk; 500mg 1000tk; 500mg 14tk; 500mg 12tk; 500mg 20tk; 500mg 100tk; 500mg 16tk; 500mg 10tk; 500mg 7tk